These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1517902)

  • 21. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.
    Carbone M; Rizzo P; Powers A; Bocchetta M; Fresco R; Krausz T
    Anticancer Res; 2002; 22(6B):3443-8. PubMed ID: 12552937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rare malignant tumors of the lungs (44 cases)].
    Grigor'eva SP; Revzis MG
    Vopr Onkol; 1979; 25(2):24-23 concl. PubMed ID: 581813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histologic aspects of pleural mesothelioma].
    Mzabi Regaya S; Makni MK; Chadli A
    Arch Inst Pasteur Tunis; 1987 Oct; 64(4):399-409. PubMed ID: 3327479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Problems in mesothelioma diagnosis.
    Addis B; Roche H
    Histopathology; 2009 Jan; 54(1):55-68. PubMed ID: 19054156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Carcinosarcomas of the lung].
    Kniazeva GD; Kiseleva NP; Minkina SM
    Arkh Patol; 1981; 43(8):69-71. PubMed ID: 7295067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
    Saad RS; Cho P; Liu YL; Silverman JF
    Diagn Cytopathol; 2005 Mar; 32(3):156-9. PubMed ID: 15690334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma.
    Friedman HD; Litovsky SH; Abraham JL
    Arch Pathol Lab Med; 1993 Oct; 117(10):967. PubMed ID: 8215835
    [No Abstract]   [Full Text] [Related]  

  • 29. Localized benign biphasic mesothelioma of the pleura.
    Bürrig KF
    Histopathology; 1987 Sep; 11(9):983-6. PubMed ID: 2444525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electron microscopy and immunohistochemistry studies of pulmonary carcinosarcomas expressing the transcription factor MEF-2 and showing significant cell-to-cell, cell-to-matrix, and epithelial-mesenchymal interactions.
    Yamazaki K
    Virchows Arch; 2004 Jun; 444(6):542-53. PubMed ID: 15083359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant sarcomatoid mesothelioma of the pleura: a histological and immunohistological study of a case.
    Avellini C; Alampi G; Cocchi V; Sabattini E; Agosti R; Schiavina M; Pileri S; Piccaluga A
    Pathologica; 1991; 83(1085):335-40. PubMed ID: 1923633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cadherin, E-selectin and vascular cell adhesion molecule: immunohistochemical markers for differentiation between mesothelioma and metastatic pulmonary adenocarcinoma?
    Müller AM; Weichert A; Müller KM
    Virchows Arch; 2002 Jul; 441(1):41-6. PubMed ID: 12111199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
    Yuasa H; Tomoyasu M
    Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma simulating mesothelioma.
    Corrin B; Dewar A
    Ultrastruct Pathol; 1996; 20(4):327-9. PubMed ID: 8837338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early and differential cytologic diagnosis in lung cancer].
    Niţu M; Măceşanu VA; Niţu M; Mărăşescu G
    Pneumologia; 2003; 52(2):126-8. PubMed ID: 14702717
    [No Abstract]   [Full Text] [Related]  

  • 38. Foamy cell mesothelioma.
    Cavazza A; Pasquinelli G; Agostini L; Leslie KO; Colby TV
    Histopathology; 2002 Oct; 41(4):369-71. PubMed ID: 12383224
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electron microscopy in the diagnosis of pleural mesothelioma].
    Canepa M
    Pathologica; 1976; 68(977-978):75-83. PubMed ID: 1018978
    [No Abstract]   [Full Text] [Related]  

  • 40. High-grade neuroendocrine carcinoma of the lung presenting an unusual spread mimicking pleural mesothelioma associated with dermatomyositis.
    Murakami Y; Kanazawa K; Okuno K; Maekawa S; Matsuda Y; Miyamoto Y; Nishimura Y; Kanomata N; Ohbayashi C; Hashimoto M; Akita H
    Am J Med Sci; 2004 Apr; 327(4):227-30. PubMed ID: 15084919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.